UK markets closed
NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.74 (-0.93%) GOLD FUTURES
2,423.30 -15.20 (-0.62%) DOW
39,835.45 +28.68 (+0.07%) Bitcoin GBP
54,872.56 +857.26 (+1.59%)
JCR Pharmaceuticals Co., Ltd. (JCRRF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 10:46AM EDT. Market open.
| Previous close | 6.20 |
| Open | 5.22 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 5.22 - 5.22 |
| 52-week range | 5.22 - 10.76 |
| Volume | |
| Avg. volume | 1 |
| Market cap | 651.477M |
| Beta (5Y monthly) | 0.01 |
| PE ratio (TTM) | 18.64 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.13 (2.47%) |
| Ex-dividend date | 27 Sept 2024 |
| 1y target est | N/A |
- Business Wire
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
HYOGO, Japan, March 19, 2024--JCR Pharmaceuticals announces achievement of milestone using J-Brain Cargo® for neurodegenerative disease in research collaboration with Alexion.
- Business Wire
JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community
HYOGO, Japan, February 29, 2024--JCR Pharmaceuticals celebrates Rare Disease Day 2024 and highlights its commitment to the rare disease community.
- Business Wire
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders
HYOGO, Japan, February 14, 2024--JCR announced the presentation of several datasets demonstrating the potential benefits of its investigational LSD therapies at the WORLDSymposium™.
© 2024 Yahoo. All rights reserved.